Gösterge TablosuPortföylerİzleme ListesiToplulukKeşfedinScreener
NOT FOR DISTRIBUTION

Victrex plc

LSE:VCT Stok Raporu

Piyasa değeri: UK£843.8m

  • Şirkete Genel Bakış
    • Değerleme
    • Gelecekteki Büyüme
    • Geçmiş Performans
    • Finansal Sağlık
    • Temettü
  • Yönetim
  • Sahiplik
  • Diğer Bilgiler
  • Hisse Senedi Topluluğu

Victrex Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Victrex şirketinin kazançları yıllık ortalama -31.6% oranında azalırken, Chemicals sektörünün kazançları yıllık 19.8% oranında artan oldu. Gelirler yıllık ortalama 1.1% oranında azalan oldu.

Anahtar bilgiler

-31.55%

Kazanç büyüme oranı

-31.61%

EPS büyüme oranı

Chemicals Sektör Büyümesi4.35%
Gelir büyüme oranı-1.12%
Özkaynak getirisi-10.67%
Net Marj-6.70%
Son Kazanç Güncellemesi31 Mar 2026

Yakın geçmiş performans güncellemeleri

Analiz Makalesi • Dec 10

We Like The Quality Of Victrex's (LON:VCT) Earnings

Shareholders appeared to be happy with Victrex plc's ( LON:VCT ) solid earnings report last week. This reaction by the...
Analiz Makalesi • May 19

We Think Victrex's (LON:VCT) Healthy Earnings Might Be Conservative

The market seemed underwhelmed by the solid earnings posted by Victrex plc ( LON:VCT ) recently. We have done some...

Recent updates

User avatar
Anlatı Güncellemesi • Sep 09

VCT: Profit Improvement Plan And Leadership Transition Will Shape Future Re Rating

Analysts have raised their price target on Victrex from £8.49 to £9.70, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations. What’s in the News for Victrex Victrex appointed Chris Gilbert as Interim Chief Financial Officer, effective 1 September 2026, with experience at Elementis plc and Deloitte LLP, according to company disclosures.
User avatar
Anlatı Güncellemesi • Jun 22

VCT: Margin Progress And Lower P/E Framework Will Support Future Re Rating

Analysts have nudged their Victrex price target slightly lower to £8.49 from £8.51, citing updated assumptions around revenue growth, profit margins and future P/E expectations that leave the overall valuation broadly unchanged. What's in the News No recent Victrex specific news items or key developments were available from the provided sources.
User avatar
Anlatı Güncellemesi • Jun 05

VCT: Updated Discount Rate And P E Assumptions Will Shape Future Rerating

Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E multiples that slightly reshape the company’s risk and return profile. What's in the News No recent company specific news for Victrex has been provided in the available sources.
User avatar
Anlatı Güncellemesi • May 21

VCT: Margin Execution And Lower P/E Framework Will Support Future Re Rating

Analysts have trimmed their implied price target on Victrex by about £0.39, citing updated assumptions around profit margins, revenue growth and a lower future P/E multiple following recent Street research. Analyst Commentary Street research around Victrex has shifted to a more cautious stance on valuation, with the latest move being a £1.00 cut to the implied price target from JPMorgan.
User avatar
Anlatı Güncellemesi • May 01

VCT: Cautious P E And Discount Rate Assumptions Will Shape Future Rerating

Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. These changes modestly adjust their outlook on the shares.
User avatar
Anlatı Güncellemesi • Apr 17

VCT: Cautious Growth And Margin Assumptions Will Shape Future P E Rerating

Analysts have lowered their price target on Victrex by £1.00, citing updates to assumptions around discount rate, revenue growth, profit margin and future P/E that collectively suggest a more balanced risk and return profile. Analyst Commentary Recent commentary around Victrex has tilted more cautious, with the latest £1.00 cut in the price target, including the 100 GBp adjustment referenced in recent research, highlighting increased focus on valuation and execution risks.
User avatar
Anlatı Güncellemesi • Apr 03

VCT: Refined Cash Flow Assumptions Will Support Future Re Rating Potential

Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around discount rates, revenue growth, and profit margins as key drivers of the revision. Analyst Commentary JPMorgan has reduced its price target on Victrex by £1.00, reflecting refreshed assumptions around discount rates, revenue growth, and margins.
User avatar
Anlatı Güncellemesi • Mar 19

VCT: Future Upside Will Be Anchored By Resilient Earnings Framework

Analysts have trimmed their price target on Victrex by £1.00, reflecting slightly lower fair value estimates and modestly softer assumptions for revenue growth and profit margins, while still using a similar discount rate and future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts view the £1.00 reduction in the price target as a fine tuning of fair value rather than a shift in the long term thesis, with the core assumptions on discount rate and future P/E multiple kept broadly intact.
User avatar
Anlatı Güncellemesi • Mar 05

VCT: Future Upside Will Be Supported By Resilient Earnings Assumptions

Analysts have trimmed their price target for Victrex to £7.32 from £7.48. This reflects updated views on its long term fair value, discount rate, revenue growth, profit margin and future P/E assumptions.
User avatar
Anlatı Güncellemesi • Feb 19

VCT: Higher Growth Assumptions Will Set Up Future Re Rating Opportunity

Analysts have trimmed their price target for Victrex to £8.90. This reflects slightly higher assumed discount and revenue growth rates, together with a small adjustment to forecast profit margins and future P/E expectations.
User avatar
Anlatı Güncellemesi • Feb 05

VCT: Sector Downgrade And Lower Future P E Multiple Will Cap Rerating Potential

Analysts have trimmed their price expectations for Victrex, reflecting slightly higher discount rate assumptions, modestly different revenue growth and profit margin forecasts, and a lower future P/E multiple in light of more cautious sector views on European chemicals. Analyst Commentary Bearish analysts have taken a more cautious stance on Victrex, in line with a broader push to reduce risk within European chemicals.
Analiz Makalesi • Jan 27

Does Victrex (LON:VCT) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
User avatar
Anlatı Güncellemesi • Jan 22

VCT: Sector Downgrade Will Set Up Opportunity For Future Re‑Rating

Analysts have reduced their fair value estimate for Victrex from £11.00 to £8.90, citing more cautious views on diversified chemicals and a preference for other parts of the European chemicals sector as key drivers of the updated price target assumptions. Analyst Commentary Recent research highlights a more cautious stance on diversified chemicals, with Victrex now grouped alongside peers where sentiment is restrained compared with preferred sub sectors such as industrial gases, ingredients, and distributors.
Analiz Makalesi • Jan 09

Victrex (LON:VCT) Has Affirmed Its Dividend Of £0.4614

The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend of £0.4614 per share on the 27th of...
User avatar
Anlatı Güncellemesi • Jan 08

VCT: Future Upside Will Be Driven By Resilient Earnings Power

Narrative Update Analysts have trimmed their fair value estimate for Victrex to reflect a lower price target of £9.40 from £11.00, citing a more cautious stance on European chemicals while still noting relatively steady assumptions for growth, margins and future P/E. Analyst Commentary Recent research updates on Victrex point to a more mixed stance, with some analysts maintaining a constructive view on the shares and others taking a more cautious approach to the broader European chemicals space.
User avatar
Anlatı Güncellemesi • Dec 24

VCT: Sector Caution And Rating Downgrade Will Pressure Share Rerating Potential

Analysts have trimmed their fair value estimate for Victrex from £6.75 to £5.75, reflecting a slightly higher discount rate, softer medium term revenue and margin expectations, and recent price target cuts from the Street. Analyst Commentary Recent Street updates underline a more cautious stance on Victrex, with bearish analysts revising ratings and price targets lower in response to sector headwinds and company specific execution risks.
Analiz Makalesi • Dec 24

Victrex (LON:VCT) Is Due To Pay A Dividend Of £0.4614

The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend on the 27th of February, with investors...
User avatar
Anlatı Güncellemesi • Dec 10

VCT: Future Upside Will Be Driven By Medical Volume Rebound

Analysts have trimmed their price targets on Victrex, cutting the implied fair value by roughly 2 percent to reflect softer margin expectations and sector headwinds, even as they acknowledge improving revenue growth prospects along with a higher future P/E multiple. Analyst Commentary Street commentary on Victrex has become more balanced, with recent notes highlighting both improving medium term growth prospects and persistent execution risks that could cap near term upside.
Analiz Makalesi • Dec 10

We Like The Quality Of Victrex's (LON:VCT) Earnings

Shareholders appeared to be happy with Victrex plc's ( LON:VCT ) solid earnings report last week. This reaction by the...
Analiz Makalesi • Dec 05

Victrex (LON:VCT) Has Announced A Dividend Of £0.4614

Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 27th of February. Based on this payment, the dividend...
User avatar
Anlatı Güncellemesi • Nov 26

VCT: Future Recovery Will Be Driven By Medical Volume Rebound

Victrex's analyst price targets have been revised downward, with a notable reduction from previous estimates such as 1,100 GBp to 940 GBp. Analysts cite ongoing caution towards the European chemicals sector and softer expectations for the company's recovery. Analyst Commentary Recent analyst assessments reflect a shift in sentiment towards Victrex's near-term performance and sector positioning.
User avatar
Anlatı Güncellemesi • Nov 11

VCT: Future Leadership Transition Will Guide Recovery As Margins Improve

Analysts have reduced their price targets for Victrex, with consensus moving from approximately £8.77 to £8.11 per share. This reflects concerns about weaker profit margins and slower growth forecasts in the chemicals sector.
Analiz Makalesi • Oct 11

Market Participants Recognise Victrex plc's (LON:VCT) Earnings

When close to half the companies in the United Kingdom have price-to-earnings ratios (or "P/E's") below 16x, you may...
Analiz Makalesi • Jun 28

Capital Allocation Trends At Victrex (LON:VCT) Aren't Ideal

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Analiz Makalesi • May 19

We Think Victrex's (LON:VCT) Healthy Earnings Might Be Conservative

The market seemed underwhelmed by the solid earnings posted by Victrex plc ( LON:VCT ) recently. We have done some...
Analiz Makalesi • May 15

Victrex's (LON:VCT) Dividend Will Be £0.1342

Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.1342 per share on 27th of June. This makes the...
User avatar
Yeni Anlatı • May 12

China Plant And Magma Programme Will Expand Market Reach

Initiatives like Project Vista and the new China plant aim to improve sales strategies and expand geographically, enhancing margins and growth potential.
Analiz Makalesi • Apr 08

With A 31% Price Drop For Victrex plc (LON:VCT) You'll Still Get What You Pay For

Victrex plc ( LON:VCT ) shareholders that were waiting for something to happen have been dealt a blow with a 31% share...
Analiz Makalesi • Mar 24

Victrex (LON:VCT) Is Finding It Tricky To Allocate Its Capital

When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...
Analiz Makalesi • Feb 26

Are Investors Undervaluing Victrex plc (LON:VCT) By 49%?

Key Insights Victrex's estimated fair value is UK£18.18 based on 2 Stage Free Cash Flow to Equity Victrex's UK£9.32...
Analiz Makalesi • Jan 15

Victrex (LON:VCT) Is Paying Out A Dividend Of £0.4614

Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 21st of February. Based on this payment, the dividend...
Analiz Makalesi • Dec 06

Victrex plc (LON:VCT) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Victrex plc ( LON:VCT ) shareholders would be excited to see that the share price has had a great month, posting a 25...
Analiz Makalesi • Sep 13

Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analiz Makalesi • Aug 03

Shareholders Should Be Pleased With Victrex plc's (LON:VCT) Price

With a price-to-earnings (or "P/E") ratio of 29.8x Victrex plc ( LON:VCT ) may be sending very bearish signals at the...
Analiz Makalesi • Jul 16

Does Victrex (LON:VCT) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analiz Makalesi • Jun 14

There Are Reasons To Feel Uneasy About Victrex's (LON:VCT) Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analiz Makalesi • May 27

Calculating The Fair Value Of Victrex plc (LON:VCT)

Key Insights Victrex's estimated fair value is UK£14.70 based on 2 Stage Free Cash Flow to Equity With UK£12.96 share...
Analiz Makalesi • Mar 16

Does Victrex (LON:VCT) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analiz Makalesi • Feb 24

Returns On Capital At Victrex (LON:VCT) Paint A Concerning Picture

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
Analiz Makalesi • Jan 12

Victrex plc Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next

Shareholders might have noticed that Victrex plc ( LON:VCT ) filed its annual result this time last week. The early...
Analiz Makalesi • Dec 08

Victrex (LON:VCT) Will Pay A Dividend Of £0.4614

Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.4614 per share on 23rd of February. This means...
Analiz Makalesi • Nov 23

Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Analiz Makalesi • Oct 19

Is Victrex plc (LON:VCT) Trading At A 22% Discount?

Key Insights Victrex's estimated fair value is UK£17.25 based on 2 Stage Free Cash Flow to Equity Victrex's UK£13.47...

Gelir ve Gider Dağılımı

Victrex nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

LSE:VCT Gelir, gider ve kazançlar (GBP Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Mar 26294-206719
31 Dec 2529346619
30 Sep 25293286519
30 Jun 25295297219
31 Mar 25298307818
31 Dec 24294236718
30 Sep 24291175718
30 Jun 24288244718
31 Mar 24284313818
31 Dec 23296465118
30 Sep 23307626319
30 Jun 23325676222
31 Mar 23343726125
31 Dec 22342746220
30 Sep 22341766216
30 Jun 22328735916
31 Mar 22316705616
31 Dec 21311725516
30 Sep 21306735416
30 Jun 21286645016
31 Mar 21265544717
31 Dec 20266544717
30 Sep 20266544717
30 Jun 20283724917
31 Mar 20300895218
31 Dec 19297915218
30 Sep 19294925318
30 Jun 19300965418
31 Mar 19305995617
31 Dec 183161056017
30 Sep 183261116417
30 Jun 183261136616
31 Mar 183261156915
31 Dec 173081076315
30 Sep 172901005615
30 Jun 17278925214
31 Mar 17266844814
31 Dec 16259834614
30 Sep 16252834414
30 Jun 16251814414
31 Mar 16250804414
31 Dec 15257824614
30 Sep 15264844814

Kaliteli Kazançlar: VCT şu anda kârlı değil.

Büyüyen Kar Marjı: VCT şu anda kârlı değil.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: VCT kârlı değildir ve zararlar son 5 yılda yılda 31.6% oranında artmıştır.

Büyüme Hızlandırma: VCT 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: VCT kârlı olmadığından, geçmiş yıl kazanç büyümesinin Chemicals sektörüyle ( 31.6% ) karşılaştırılması zorlaşıyor.


Özkaynak Getirisi

Yüksek ROE: VCT hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -10.67% ) sahiptir.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/09/18 08:35
Gün Sonu Hisse Fiyatı2026/09/18 00:00
Kazançlar2026/03/31
Yıllık Kazançlar2025/09/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
  • SEC Form 10-K
  • SEC Form 10-Q
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
  • Analist Araştırma Raporları
  • Blue Matrix
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
  • ICE Piyasa Verileri
  • SEC Form S-1
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
  • SEC Form 4
  • SEC Form 13D
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
  • SEC Form 10-K
  • SEC Form DEF 14A
Önemli Gelişmeler10 yıl
  • Şirket duyuruları
  • SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Victrex plc 28 Bu analistlerden 11, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
James StewartBarclays
Katie RichardsBarclays
Gunther ZechmannBarclays

Her Yerde Daha İyi Yatırım Kararları Alın

İndirmek için tarayın
AppStore’u AçGoogle Play’i Aç
Chrome Web Mağazası
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Veri Kaynaklarını Görüntüle
Piyasalar
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Yatırım Fikirleri
  • Değeri Düşük Şirketler
  • Temettü Santralleri
  • İçeriden Satın Alma
  • Nükleer Enerji
  • Otonom Araçlar
  • Yapay Zeka
  • Kripto ve Blok Zinciri
  • Siber güvenlik
  • Daha fazla fikir
Hisse Toplulukları
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Araçlar ve özellikler
  • Portföy Takibi
  • Hisse Senedi Tarayıcı & Uyarılar
  • Anlatılar ve Adil Değerler
  • Temettü Hesaplayıcı
Haberler ve Keşifler
  • Son Hisse Senedi Haberleri
  • Küresel Pazar İçgörüleri
  • Foxhole
  • Yatırım Fikirleri
  • Topluluk Anlatıları
  • Yenilikler
Simply Wall St
  • Planlar & Fiyatlandırma
  • Reklam
  • Hakkımızda
  • Bize Ulaşın
  • Kariyer
  • Yardım Merkezi
  • Hisse Senedi Yatırımını Öğrenin
  • Ortaklık Programı
  • İşletme ve Kurumsal
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Şartlar ve Koşullar
  • Gizlilik Politikası
  • Yapay Zeka Koşulları
  • Finansal Hizmetler Rehberi